Vimarsana
Biggest News Aggregation in the World

Page 19 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alkermes Today - Breaking & Trending Today

Global Schizophrenia Treatment Market Report Sheds Light on - Vimarsana News

Global Schizophrenia Treatment Market Report Sheds Light on

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The

Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 5.6% - Vimarsana News

Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 5.6%

Alkermes plc (NASDAQ:ALKS – Get Free Report) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 13,230,000 shares, a decline of 5.6% from the December 31st total of 14,020,000 shares. Based on an average trading volume of 2,630,000 shares, the […]

Adjuvant Pembrolizumab Significantly Prolongs OS vs Placebo in ccRCC - Vimarsana News

Adjuvant Pembrolizumab Significantly Prolongs OS vs Placebo in ccRCC

Treatment with adjuvant pembrolizumab significantly improved overall survival vs placebo in patients with clear cell renal cell carcinoma.

Carlow Nationalist — 'Skinny jab' maker Novo Nordisk facing opposition over proposed €2bn Dublin facility - Vimarsana News

Carlow Nationalist — 'Skinny jab' maker Novo Nordisk facing opposition over proposed €2bn Dublin facility

The Danish pharma giant said up to 2,000 workers will be employed during the construction…

Plans by Ozempic 'skinny jab' maker for €2bn Dublin factory expansion spark local objections - Vimarsana News

Plans by Ozempic 'skinny jab' maker for €2bn Dublin factory expansion spark local objections

Local residents have voiced concern about plans for an estimated €2 billion expansion of its Irish operations by a leading pharmaceutical firm seeking to increase production of its best-selling weight loss and diabetes medicines.